Education
About Us
Working with TipRanks
Follow Us
AngioDynamics (ANGO)
NASDAQ:ANGO
ANGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.47 - $13.50
Previous CloseN/A
Volume2.49M
Average Volume (3M)498.46K
Market Cap
$397.78M
Enterprise Value$234.41M
Total Cash (Recent Filing)$54.09M
Total Debt (Recent Filing)$4.96M
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Apr 02, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.58
Shares Outstanding40,465,710
10 Day Avg. Volume472,259
30 Day Avg. Volume498,461
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.40
Price to Cash Flow (P/CF)40.60
P/FCF Ratio40.60
Enterprise Value/Market Cap0.59
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.52
Enterprise Value/Ebitda-16.24
Forecast
1Y Price Target
$15.33Price Target Upside55.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
AngioDynamics News
PremiumCompany Announcements
AngioDynamics Earnings Call Highlights Med Tech Growth
PremiumCompany Announcements
AngioDynamics Highlights Strategic Growth at Healthcare Conference
PremiumCompany Announcements
AngioDynamics, Inc. Reports Growth in Med Tech Segment---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTop and bottom-line beat in F2Q25; FY25 adjusted EBITDA guidance increased.
Market ExpansionThe FDA clearance should enable the company to expand the commercial footprint of NanoKnife, which could help drive the company’s Med Tech sales growth.
Product ApprovalFDA approves NanoKnife System for prostate tissue ablation.
Bears Say
Market CompetitionThe expected presentation of full trial data at the American Urological Association annual meeting could potentially drive further awareness, but also intensify scrutiny and competition in the field.
Regulatory ChallengesThe benefit will mainly be from more streamlined access for therapy with the CAT I code, with likely fewer prior authorization hurdles for patients and providers seeking to utilize the therapy, yet these changes might not fully eliminate regulatory and reimbursement challenges.
---
Ownership Overview
4.16% Insiders
18.51% Mutual Funds
25.76% Other Institutional Investors
38.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ANGO FAQ
What was AngioDynamics’s price range in the past 12 months?
AngioDynamics lowest stock price was $5.47 and its highest was $13.50 in the past 12 months.
What is AngioDynamics’s market cap?
AngioDynamics’s market cap is $397.78M.
When is AngioDynamics’s upcoming earnings report date?
AngioDynamics’s upcoming earnings report date is Apr 02, 2025 which is in 4 days.
How were AngioDynamics’s earnings last quarter?
AngioDynamics released its earnings results on Jan 08, 2025. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.11 by $0.07.
Is AngioDynamics overvalued?
According to Wall Street analysts AngioDynamics’s price is currently Undervalued.
Does AngioDynamics pay dividends?
AngioDynamics does not currently pay dividends.
What is AngioDynamics’s EPS estimate?
AngioDynamics’s EPS estimate is -0.13.
How many shares outstanding does AngioDynamics have?
AngioDynamics has 40,465,710 shares outstanding.
What happened to AngioDynamics’s price movement after its last earnings report?
AngioDynamics reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.11. Following the earnings report the stock price went up 37.66%.
Which hedge fund is a major shareholder of AngioDynamics?
Currently, no hedge funds are holding shares in ANGO
---
AngioDynamics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.33 (55.95% Upside)
$15.33 (55.95% Upside)
Blogger Sentiment
Bullish
ANGO Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 161.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $50.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
72.45%
12-Months-Change
Fundamentals
Return on Equity
-76.44%
Trailing 12-Months
Asset Growth
-41.65%
Trailing 12-Months
Company Description
AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical, surgical, and diagnostic devices used by professional healthcare providers for the minimally invasive treatment of cancer and peripheral vascular disease. The company operates in the healthcare sector, focusing on the development and commercialization of products that improve patient outcomes and reduce healthcare costs. AngioDynamics markets a wide range of devices, including radiofrequency ablation systems, vascular access products, and thrombolytic products, serving hospital, outpatient center, and physician office markets globally.
---
ANGO Company Deck
---
ANGO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance in revenue growth and profitability, especially within the Med Tech segment, driven by innovations like AlphaVac and NanoKnife. However, challenges persist in Med Device revenue stagnation and manufacturing transition costs, tempering overall financial improvements.Read More>---
ANGO Stock 12 Month Forecast
Average Price Target
$15.33
▲(55.95% Upside)
Technical Analysis
Best Analysts Covering ANGO
1 Year
1 Year Success Rate
10/12 ratings generated profit
1 Year Average Return
+30.97%
reiterated a buy rating 3 months ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +30.97% per trade.
---